Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S. Paller(Northwestern University), Adelaide A. Hebert(The University of Texas Health Science Center), Mark Lebwohl(Mount Sinai Hospital), Andrea L. Zaenglein(Penn State Milton S. Hershey Medical Center), Matilda H. Hughes, William C. Rees, Wynnis L. Tom(Rady Children's Hospital-San Diego), Linda Stein Gold(Henry Ford Health System), Robin L. Blumenthal, Mark Boguniewicz(University of Colorado Denver), Douglass W. Forsha(Jordan Valley Dermatology), Lawrence F. Eichenfield(University of California San Diego), Lee T. Zane, Mary Spellman, Robert S. Call, Eric L. Simpson(Oregon Health & Science University)
Cited by 564
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2013|1.3k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2014|1.2k
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917